Aug 6, 2026

Featuring perspectives from Dr Yelena Y Janjigian, Dr Manish A Shah and Prof Eric Van Cutsem, moderated by Dr Janjigian, including the following topics:

• Introduction (0:00)
• HER2-Targeted Approaches in Advanced Gastroesophageal Cancers — Prof Van Cutsem (2:08)
• Targeting CLDN18.2 in Advanced Gastroesophageal Cancers...

Jul 28, 2026

Featuring perspectives from Dr Tanios Bekaii-Saab, Dr Stacey A Cohen and Dr Arvind Dasari, moderated by Dr Bekaii-Saab, including the following topics:

• Introduction (0:00)
• Current and Future Role of Immune Checkpoint Inhibition in the Management of Microsatellite Instability-High/Mismatch Repair Deficient Localized and...

Jun 22, 2026

Featuring perspectives from Dr Kristen K Ciombor and Dr John Strickler, including the following topics:

• Introduction (0:00)
• Current and Future Role of Immune Checkpoint Inhibitors in the Management of Colorectal Cancer (CRC) — Dr Ciombor (3:58)
• Other Recent Advances in CRC Management — Dr Strickler (32:57)

CME...

Jun 19, 2026

Featuring perspectives from Dr Yelena Y Janjigian and Dr Samuel J Klempner, including the following topics:

• Introduction (0:00)
• Role of Anti-PD-1/PD-L1- and CLDN18.2-Directed Antibodies in the Management of Gastroesophageal Cancers — Dr Klempner (5:52)
• Management of HER2-Positive Gastroesophageal Cancers — Dr...

Jun 15, 2026

Featuring perspectives from Dr Eileen M O’Reilly and Dr Philip A Philip, including the following topics:

• Introduction (0:00)
• Optimal Incorporation of Chemotherapy into the Management of Advanced Pancreatic Cancer — Dr Philip (7:27)
• Other Available and Emerging Novel Approaches for Pancreatic Cancer — Dr...